Loading provider…
Loading provider…
Pulmonary Disease Physician in Baltimore, MD
NPI: 1003843657Primary Practice Location
JOHNS HOPKINS BAYVIEW MEDICAL CENTER
4940 Eastern Ave, Baltimore, MD
Primary Employer
Jhu - Medicine/Pulmonary
hopkinsmedicine.org
HQ Phone
Get M.D. Robert's Phone NumberMobile
Get M.D. Robert's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 94729Measurement of lung diffusing capacity | 1,123 | 1,278 |
| 2 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 979 | 1,164 |
| 3 | 94727Test to determine lung volumes using gas dilution or washout | 929 | 1,046 |
| 4 | 94060Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | 360 | 365 |
| 5 | 94726Determination of lung volumes using plethysmography | 141 | 142 |
Authors: Tal-Singer, Ruth, Willard, Kristen S, Luttmann, Mark A, Sprankle, Madison, Reynolds, Jenna, Muerza Santos, Irantzu, Jaffee, Hannah, Vichiendilokkul, Anna, Jacomelli, Cristina, Novak, Špela, Gascon Moreno, Victor, Wise, Robert A
Journal: Patient Prefer Adherence
Publication Date: 2025-04-28
Urbanization and Daily Exposure to Biomass Fuel Smoke Both Contribute to Chronic Bronchitis Risk in a Population with Low Prevalence of Daily Tobacco Smoking.
Authors: Gregory Diette, Devan Jaganath
Publication Date: 2016-03
Authors: Kevin Murphy, Joan Reibman, Ileen Gilbert, Bradley Chipps, David Beuther
Journal: J Asthma Allergy
Publication Date: 2024-08-07
Lead Sponsor: Verona Pharma plc
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: Placebo, DRUG: Ensifentrine
Lead Sponsor: Sanofi
Collaborators: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Dupilumab SAR231893, DRUG: Inhaled Corticosteroid, DRUG: Inhaled Long-Acting Beta Agonist, DRUG: Inhaled Long-Acting Muscarinic Antagonist
Lead Sponsor: Brigham and Women's Hospital
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)